Commentary: The public health consequences of an industry-influenced psychiatric taxonomy: "Attenuated Psychotic Symptoms Syndrome" as a case example

Accountability in Research

Volumn 17, Issue 5, 2010, Pages 264-269

  Gopal, Abilash A ^a   Cosgrove, Lisa ^b   Bursztajn, Harold J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antipsychotics; Attenuated psychotic symptoms syndrome; Atypicals; Diagnosis; DSM V; Pharmaceutical industry

Indexed keywords

ARTICLE; CLASSIFICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUSTRY; HUMAN; PATHOPHYSIOLOGY; PSYCHOSIS; PUBLIC HEALTH; SYNDROME;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUSTRY; HUMANS; PSYCHOTIC DISORDERS; PUBLIC HEALTH; SYNDROME;

EID: 77957662960     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/08989621.2010.511568     Document Type: Article

References (16)

1. American Psychiatric Association (2010) Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition, Proposed Revisions. Washington, D.C.: American Psychiatric Association.
2. Buono, D. IMS study finds decline in prescription drug market growth. Drug Store News, 21 April 2008. Available at http://findarticles.com/p/articles/mi_m3374/is_5_30/ai_n25407255?tag=artBody;c011. Accessed July, 1, 2009.
3. Bursztajn, H. J., Feinbloom, R. I., Hamm, R. M., and Brodsky, A. (1981). Medical Choices, Medical Chances: How Patients, Families, and Physicians Can Cope with Uncertainty. New York: Delacorte.
4. Correll, C. U., Manu, P., Olshanskiy, V., Napolitano, B., Kane, J. M., and Malhotra, A. K. (2009). Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA, 302(16): 1765-1773.
5. Cosgrove, L., Bursztajn, H., and Krimsky, S. (2009). Developing unbiased diagnostic and treatment guidelines in psychiatry. New England Journal of Medicine, 360:2035-2036.
6. de Koning, M. B., Bloemen, O. J. N., van Amelsvoort, T. A. M. J., Becker, H. E., Nieman, D. H., van der Gaag, M., and Linszen, D. H. (2009). Early intervention in patients at ultra high risk of psychosis: benefits and risks. Acta Psychiatr. Scand., 119(6): 426-442.
7. Devro, D. (2007). The Secret History of the War on Cancer. New York: Basic Books.
8. Elliott, K. (2008). Scientific judgment and the limits of conflict-of-interest policies. Accountability in Research, 15:1-29.
9. IMS Health. (2008). U.S. Sales and Prescription Information: Top Therapeutic Classes by U.S. Sales.
10. Makhinson, M. (2010). Biases in medication prescribing: The case of second generation antipsychotics. J. Psychiatr. Pract., 16:15-21.
11. McGlashan, T. H., Zipursky, R. B., Perkins, D., Addington, J., Miller, T., Woods, S. W., Hawkins, K. A., Hoffman, R. E., Preda, A., and Epstein, I. (2006). Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am. J. Psychiatry, 163:790-799.
12. McGorry, P. D., Nelson, B., Amminger, P., Bechdolf, A., Francey, S. M., Berger, G., Riecher-Rossler, A., Klosterkotter, J., Ruhrmann, S., Schultz-Lutter, F., Nordentoft, M., Hicki, I., McGuire, P., Berk, M., Chen, E. Y. H., Keshavan, M. S., and Yung, A. R. (2009). Intervention in individuals at ultra high risk for psychosis: a review and future directions. J. Clin. Psychiatry, 70(9): 1206-1212.
13. McHenry, L. B. and Jureidini, J. N. (2008). Industry sponsored ghostwriting in clinical trial reporting: A case study. Accountability in Research,15:152-167.
14. Rüsch, N., Corrigan, P. W., Todd, A. R., and Bodenhausen, G. V. (2010). Implicit selfstigma in people with mental illness. J. Nerv. Ment. Dis.,198:150-153.
15. Woods, S. W., Addington, J., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., Heinssen, R., Perkins, D. O., Seidman, L. J., Tsuang, M. T., Walker, E. F., and McGlashan, T. H. (2009). Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull, 35(5): 894-908.
16. Yung, A. R., Nelson, B., Stanford, C., Simmons, M. B., Cosgrave, E. M., Killackey, E., Phillips, L. J., Bechdolf, A., Buckby, J., and McGorry, P. D. (2008). Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res, 105(1-3):10-17.